You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


MRI in Breast Cancer: Assessment of Response to Neoadjuvant Therapy

  • Authors: Elizabeth A. Morris, MD; Joyce A. O’Shaughnessy, MD
  • CME / ABIM MOC Released: 11/30/2022
  • Valid for credit through: 11/30/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.00 ABIM MOC points

    ARRT - 1.0 American Registry of Radiologic Technologists (ARRT) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for radiologists, radiologic technologists, oncologists, pathologists, obstetricians & gynecologists, radiation oncologists, surgeons (including surgical oncologists), primary care physicians (PCPs), internal medicine specialists, nurses/nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with or at risk of breast cancer.

The goal of this activity is for the learner to be better able to use imaging to accurately assess treatment response to neoadjuvant therapy and effectively collaborate to provide patients with the best possible options for treatment of their early breast cancer.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Role of MRI in assessing treatment response to neoadjuvant therapy in patients with early breast cancer
    • Importance of collaboration between radiology and oncology that is essential for improving treatment of patients with breast cancer
  • Demonstrate greater confidence in their ability to
    • Utilize MRI to inform treatment decisions for patients undergoing adjuvant treatment of breast cancer


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


  • Elizabeth A. Morris, MD

    Breast Radiology and Imaging Co-Chair
    Professor and Chair, Department of Radiology
    University of California
    Davis School of Medicine
    Sacramento, California


    Elizabeth A. Morris, MD, has no relevant financial relationships.

  • Joyce A. O'Shaughnessy, MD

    Conference Chair
    Celebrating Women Chair in Breast Cancer Research
    Baylor University Medical Center
    Director, Breast Cancer Research Program
    Texas Oncology
    US Oncology Research Network
    Dallas, Texas


    Joyce A. O'Shaughnessy, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Agendia; Amgen Biotechnology; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene Corporation; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme Therapeutics; Heron Therapeutics; Immunomedics; Ipsen Biopharmaceuticals; Lilly; Merck; Myriad; Nektar Therapeutics; Novartis; Ontada; Pfizer; Pharmacyclics; Pierre Fabre Pharmaceuticals; Puma Biotechnology; Prime Oncology; Roche; Samsung Bioepis; Sanofi; Seagen Inc.; Syndax Pharmaceuticals; Synthon; Taiho Oncology; Takeda


  • Vickie Phoenix, BS

    Medical Education Director, Medscape, LLC


    Vickie Phoenix, BS, has no relevant financial relationships.

Compliance Reviewer

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Registry of Radiologic Technologists (ARRT)
This activity has been approved by the American Society of Radiologic Technologists (ASRT) for 1.00 hours of ARRT Category A continuing education credit.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


MRI in Breast Cancer: Assessment of Response to Neoadjuvant Therapy

Authors: Elizabeth A. Morris, MD; Joyce A. O’Shaughnessy, MDFaculty and Disclosures

CME / ABIM MOC Released: 11/30/2022

Valid for credit through: 11/30/2023


A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print